BIOCRYST PHARMACEUTICALS, INC.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2021 | 95.4% | -113.1% | -117.1% |
| FY2022 | 97.6% | -54.8% | -91.2% |
| FY2023 | 98.6% | -31.3% | -68.4% |
| FY2024 | 97.3% | -0.6% | -19.7% |
| FY2025 | 97.8% | 39.0% | 30.2% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2021 | 95.4% | -113.1% | -117.1% |
| FY2022 | 97.6% | -54.8% | -91.2% |
| FY2023 | 98.6% | -31.3% | -68.4% |
| FY2024 | 97.3% | -0.6% | -19.7% |
| FY2025 | 97.8% | 39.0% | 30.2% |